Fairvalue-Calculator Fairvalue-Calculator
EN DE

Country Condo's Limited (COUNCODOS) Fair Value & Analysis

Real Estate · IN · Market cap ₹372M

Price₹4.79
Fair Value₹1.55
Upside-67.6%
Quality97/100
Evidence: High Range ₹1.12 – ₹1.99

Fair value as of: Jun 29, 2026

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Country Condo's Limited (COUNCODOS) currently trades at ₹4.79, while our model-based Fair Value estimate is ₹1.55 — implying the stock looks roughly 67.6% overvalued today. We read business quality at 97/100 (high quality), in the Real Estate sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Country Condo's Limited engages in the real estate business in India. The company procures land banks; develops residential layouts; constructs compound walls; and sells plots. It also provides contract research services. The company was formerly known as Neocure Therapeutics Ltd. and changed its name to Country Condo's Limited in December 2006. Country Condo's Limited was incorporated in 1987 and is headquartered in Hyderabad, India.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Country Condo's Limited (COUNCODOS) undervalued?
As of Jun 29, 2026, our model estimates a fair value of ₹1.55 versus a price of ₹4.79 — about −68% (overvalued). Model-based estimate, not financial advice.
What is the fair value of COUNCODOS?
Our 21-model fair value for Country Condo's Limited is ₹1.55 (as of Jun 29, 2026), built from audited fundamentals. The current price is ₹4.79.
What is the quality score of COUNCODOS?
Country Condo's Limited has a Quality Score of 97/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.